Published in Liver Transpl on November 01, 2001
Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model. PLoS One (2011) 1.43
Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg (2003) 1.26
Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg (2004) 1.24
Estimating liver weight of adults by body weight and gender. World J Gastroenterol (2006) 1.17
Current concept of small-for-size grafts in living donor liver transplantation. Surg Today (2008) 1.02
Review of the surgical approach to prevent small-for-size syndrome in recipients after left lobe adult LDLT. Surg Today (2013) 0.98
Current concepts in transplant surgery: liver transplantation today. Langenbecks Arch Surg (2008) 0.96
Small for size syndrome following living donor and split liver transplantation. World J Gastrointest Surg (2010) 0.91
Small-for-size syndrome in adult-to-adult living-related liver transplantation. World J Gastroenterol (2010) 0.90
Early graft dysfunction following adult-to-adult living-related liver transplantation: predictive factors and outcomes. World J Gastroenterol (2009) 0.89
Liver transplantation: yesterday, today and tomorrow. World J Gastroenterol (2008) 0.88
Inhalation of hydrogen gas reduces liver injury during major hepatotectomy in swine. World J Gastroenterol (2012) 0.85
Outcome of patients undergoing right lobe living donor liver transplantation with small-for-size grafts. World J Gastroenterol (2014) 0.84
Utilization of expanded criteria donors in liver transplantation. Int J Organ Transplant Med (2013) 0.83
Hepatic hemodynamic changes during liver transplantation: a review. World J Gastroenterol (2014) 0.81
Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan. World J Gastroenterol (2011) 0.80
Technical progress in living donor liver transplantation for adults. HPB (Oxford) (2004) 0.80
PREOPERATIVE COMPUTED TOMOGRAPHY VOLUMETRY AND GRAFT WEIGHT ESTIMATION IN ADULT LIVING DONOR LIVER TRANSPLANTATION. Arq Bras Cir Dig (2017) 0.79
Ratio of remnant to total liver volume or remnant to body weight: which one is more predictive on donor outcomes? HPB (Oxford) (2012) 0.79
Historical perspective of living donor liver transplantation. World J Gastroenterol (2008) 0.79
Living donor liver transplantation in the USA. Hepatobiliary Surg Nutr (2016) 0.79
Small-for-size syndrome in living-donor liver transplantation using a left lobe graft. Surg Today (2014) 0.78
Child-to-Adult Liver Transplantation With Donation After Cardiac Death Donors: Three Case Reports. Medicine (Baltimore) (2016) 0.77
Application of Induced Pluripotent Stem Cells in Liver Diseases. Cell Med (2014) 0.76
Smaller grafts do not imply early recurrence in recipients transplanted for hepatocellular carcinoma: A Chinese experience. Sci Rep (2016) 0.75
Preoperative selective desensitization of live donor liver transplant recipients considering the degree of T lymphocyte cross-match titer, model for end-stage liver disease score, and graft liver volume. J Korean Med Sci (2014) 0.75
Adult-to-adult living donor liver transplantation: Operative techniques to optimize the recipient's outcome. J Nat Sci Biol Med (2017) 0.75
Antibody-mediated rejection after adult living-donor liver transplantation triggered by positive lymphocyte cross-match combination. Ann Gastroenterol (2012) 0.75
Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience. Transplantation (2016) 0.75
Fate and Effect of Intravenously Infused Mesenchymal Stem Cells in a Mouse Model of Hepatic Ischemia Reperfusion Injury and Resection. Stem Cells Int (2016) 0.75
Mesenchymal Stromal Cell-Derived Factors Promote Tissue Repair in a Small-for-Size Ischemic Liver Model but Do Not Protect against Early Effects of Ischemia and Reperfusion Injury. J Immunol Res (2015) 0.75
Liver segmentation: indications, techniques and future directions. Insights Imaging (2017) 0.75
Is Portal Venous Pressure or Porto-systemic Gradient Really A Harbinger of Poor Outcomes After Living Donor Liver Transplantation? J Clin Exp Hepatol (2017) 0.75
Three-dimensional computed tomography analysis of variations in the middle hepatic vein tributaries: proposed new classification. Surg Today (2014) 0.75
Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. J Cell Biol (1998) 5.14
Prevalence and natural history of cryptorchidism. Pediatrics (1993) 2.79
Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem J (1998) 2.65
Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg (1999) 2.51
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res (1996) 2.18
Effects of charged amino acid mutations on the bimolecular kinetics of reduction of yeast iso-1-ferricytochrome c by bovine ferrocytochrome b5. Biochemistry (1993) 2.14
Ivermectin-resistant Ostertagia circumcincta from sheep in the lower North Island and their susceptibility to other macrocyclic lactone anthelmintics. N Z Vet J (2000) 2.07
Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett (1998) 1.96
Neurologic outcome after ascending aorta-aortic arch operations: effect of brain protection technique in high-risk patients. J Thorac Cardiovasc Surg (2001) 1.93
Investigating neural primacy in Major Depressive Disorder: multivariate Granger causality analysis of resting-state fMRI time-series data. Mol Psychiatry (2010) 1.83
Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67
Expanded indications for laser-assisted balloon angioplasty in peripheral arterial disease. J Vasc Surg (1990) 1.62
Hepatocyte growth factor: a multifunctional cytokine. Lancet (1995) 1.61
One hundred nine living donor liver transplants in adults and children: a single-center experience. Ann Surg (2001) 1.61
Hemostatic problems and thromboembolic complications in nephrotic children. Pediatr Nephrol (2000) 1.59
Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis. Ann Neurol (1997) 1.55
N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation (1995) 1.52
Interaction-induced shift of the cyclotron resonance of graphene using infrared spectroscopy. Phys Rev Lett (2010) 1.51
Brucella infection with pancytopenia after pediatric liver transplantation. Transpl Infect Dis (2012) 1.45
The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience. J Pediatr Gastroenterol Nutr (2001) 1.43
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology (1996) 1.42
Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl Surg (1997) 1.41
Retrograde cerebral perfusion during thoracic aortic surgery and late neuropsychological dysfunction. Eur J Cardiothorac Surg (2001) 1.40
Use of the superficial femoral vein as a replacement for large veins. J Vasc Surg (1991) 1.40
Arterial blood pressure and heart rate discrepancies between handwritten and computerized anesthesia records. Anesth Analg (2000) 1.40
Outcome for patients treated with laparoscopic versus open resection of hepatocellular carcinoma: case-matched analysis. Ann Surg Oncol (2009) 1.34
Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up. Clin Transplant (2000) 1.34
A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg (1995) 1.32
Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transpl Surg (1999) 1.32
Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience. Ann Surg Oncol (2000) 1.30
ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene (1997) 1.28
Etiology of chronic renal failure in Turkish children. Pediatr Nephrol (1995) 1.27
Maternal transmission of immunity to Eimeria maxima: enzyme-linked immunosorbent assay analysis of protective antibodies induced by infection. Infect Immun (1994) 1.25
Prospective study of the natural history of thoracic aortic aneurysms. Ann Thorac Surg (1997) 1.23
Preoperative and intraoperative predictors of postoperative morbidity, poor graft function, and early rejection in 190 patients undergoing liver transplantation. Arch Surg (2001) 1.20
Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol (2000) 1.19
Safety and risk of using pediatric donor livers in adult liver transplantation. Liver Transpl (2001) 1.17
Liver transplantation for autoimmune hepatitis. Hepatology (2000) 1.16
Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology (1995) 1.16
Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis (1996) 1.16
Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients. Am J Transplant (2007) 1.13
The molecular genetic analysis of the expanding pachyonychia congenita case collection. Br J Dermatol (2014) 1.13
Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation (2000) 1.12
Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg (1998) 1.11
Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study. Am J Transplant (2013) 1.11
The relationship of cognitive, personality, and academic measures to anesthesiology resident clinical performance. Anesth Analg (1999) 1.10
Safe use of hepatic allografts from donors older than 70 years. Transplantation (1996) 1.09
Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation (2001) 1.08
A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients. Pediatrics (2000) 1.07
Neonatal hemochromatosis: the importance of early recognition of liver failure. J Pediatr (2000) 1.07
Endovascular treatment of arteriovenous fistulas complicating percutaneous renal biopsy in three paediatric cases. Nephrol Dial Transplant (1999) 1.06
Liver resection under total vascular isolation. Variations on a theme. Ann Surg (1993) 1.06
Eimeria maxima gametocyte antigens: potential use in a subunit maternal vaccine against coccidiosis in chickens. Vaccine (1995) 1.05
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation (1995) 1.05
Accuracy and significance of computed tomographic scan assessment of hepatic volume in patients undergoing liver transplantation. Transplantation (2000) 1.04
Results of immediate surgical treatment of all acute type A dissections. Circulation (2000) 1.03
The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology (1998) 1.03
Infrared spectroscopy of Landau levels of graphene. Phys Rev Lett (2007) 1.03